Title : ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors.

Pub. Date : 2005 Nov 15

PMID : 16299247






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors. vandetanib epidermal growth factor receptor Mus musculus
2 EXPERIMENTAL DESIGN: ZD6474 is a novel, orally available low molecular weight inhibitor of the kinase activities associated with vascular endothelial growth factor receptor-2 and epidermal growth factor receptor. vandetanib epidermal growth factor receptor Mus musculus